Carolyn M Ecelbarger

5PUBLICATIONS
4CO-AUTHORS
Regenerative medicine (incl. stem cells)Molecular targetsDevelopmental genetics (incl. sex determination)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2024
SGLT2 inhibition leads to a restoration of hepatic and circulating metabolites involved in the folate cycle and pyrimidine biosynthesis.

Ileana Mendez Espinoza, Elijah N D Choos, Carolyn M Ecelbarger

|Apr 11, 2024
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.

Blythe D Shepard, Jennifer Chau, Ryan Kurtz

|May 13, 2023
Sex Modulates Response to Renal-Tubule-Targeted Insulin Receptor Deletion in Mice.

Soha Sohail, Gabriella Akkawi, Taylor Rechter

|Sep 23, 2022
Renal Metabolome in Obese Mice Treated with Empagliflozin Suggests a Reduction in Cellular Respiration.

Surabhi Bangarbale, Blythe D Shepard, Shivani Bansal

|Jun 23, 2021
Caloric Restriction and Cardiovascular Health: the Good, the Bad, and the Renin-Angiotensin System.

Aline M A de Souza, Carolyn M Ecelbarger, Kathryn Sandberg

Pageof 1